Newsletter
Every new paper in this field, in your inbox.
A recent analysis of 22,312 patients shows that same-day (0.9%) and short-stay (8.2%) stoma closure protocols significantly reduce overall morbidity compared to traditional inpatient stays (90.9%)—11.8%. Both expedited discharge methods demonstrate comparable safety outcomes, with the inpatient group experiencing higher reoperation rates. Despite evidence supporting…
A nationwide study reveals that 15% of patients with non-metastasized rectal cancer successfully utilized a watch and wait strategy after neoadjuvant treatment. Among those treated with chemoradiotherapy, 21% achieved favorable results, compared to just 7% for short-course radiotherapy. Organ preservation rates improved to 17% when…
A new clinical prediction model offers reliable assessment for anastomotic leakage (AL) in rectal cancer surgery, based on a study of 3,765 patients. The model identified key risk factors, including gender, diabetes, preoperative chemoradiotherapy, and surgical parameters. With area under the curve (AUC) values of…
Gastrointestinal motility agents significantly enhance recovery in patients after elective colorectal surgery, according to a systematic analysis of seven randomized controlled trials involving 849 individuals. Patients experienced accelerated gastrointestinal recovery by 1.01 days and reduced time to first bowel movement by 1.07 days. Importantly, safety…
A recent study identified ten key genes associated with colorectal cancer (CRC) stemness, revealing their correlation with disease-free and progression-free survival. Using a machine learning model, researchers found that higher mRNA expression-based stemness indexes (mrnasi) correlated with improved clinical outcomes. Notably, CRC samples with lower…
A phase II clinical trial demonstrates the feasibility of mass-based response testing (MRT) in tailoring intraperitoneal chemotherapy for patients with unresectable appendiceal or colorectal peritoneal metastases. MRT assessed tumor susceptibility to various HIPEC drug regimens, offering a personalized approach to treatment. The study aims to…
A newly established colorectal cancer-specific tertiary lymphoid structures (TLS) signature correlates with enhanced overall survival and treatment responses in patients. In the TCGA cohort, those with high TLS scores showed significantly longer survival (p=0.008) and greater complete or partial response rates (p=0.017). The study also…
A novel approach using combined surgery and endoscopic stricturotomy achieved a remarkable 100% immediate success rate in treating multi-segmental fibrotic strictures from Crohn's disease. Among 21 patients, 85.7% experienced significant symptom relief, and 90.5% returned to a regular diet within eight weeks. With a median…
Guidelines developed by the BSG/ACPGBI assist clinicians in managing colorectal polyps for patients with a life expectancy of under 10 years. The guidance outlines 33 recommendations drawn from a consensus process involving 28 experts. It includes assessments of life expectancy, polyp characteristics, and risks of…
In a comparative study of colon adenomas and early-stage cancers, endoscopic mucosal resection (EMR) significantly outperformed traditional surgery. Among 568 EMR patients and 2,054 surgical patients, EMR was associated with a lower all-cause mortality rate (hazard ratio 0.31) and reduced healthcare utilization over an average…
